Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trialDavid A. Palma, Suresh Senan, Stewart Gaede et al.|BMC Cancer|2012Cited by 308